Giacobello Scott M., Chief Financial Officer of Whitehawk Therapeutics ($WHWK), sold shares once on the open market in the last year, totaling $8,585. His most recent sale occurred on March 2, 2026. These sales rank 11,301st among 11,678 insiders in our database, where the average is $8.6 million across 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 300677 | $0.00 | 300,677.0000 | 69,204,899 | 9999.99% | 0.43% |
| April 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 473902 | $0.00 | 0.0000 | 69,204,899 | 100.00% | 0.68% |
| April 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M | Common Stock | 473902 | $0.00 | 502,002.0000 | 69,204,899 | 1686.48% | 0.68% |
| March 2, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S | Common Stock | 2594 | $3.31 | 28,100.0000 | 69,204,899 | 8.45% | 0.00% |
| March 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M | Common Stock | 6750 | $0.00 | 30,694.0000 | 69,204,899 | 28.19% | 0.01% |
| March 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 6750 | $0.00 | 13,500.0000 | 69,204,899 | 33.33% | 0.01% |
| April 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 473902 | $0.00 | 473,902.0000 | 27,029,942 | 9999.99% | 1.75% |
| April 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 473902 | $0.00 | 473,902.0000 | 27,029,942 | 9999.99% | 1.75% |
| March 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M | Common Stock | 6750 | $0.00 | 26,750.0000 | 27,029,942 | 33.75% | 0.02% |
| March 3, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S | Common Stock | 2806 | $2.35 | 23,944.0000 | 27,029,942 | 10.49% | 0.01% |
| March 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 6750 | $0.00 | 20,250.0000 | 27,029,942 | 25.00% | 0.02% |
| March 1, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 138263 | $0.00 | 138,263.0000 | 26,917,967 | 9999.99% | 0.51% |
| March 1, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 27000 | $0.00 | 27,000.0000 | 26,917,967 | 9999.99% | 0.10% |
| March 1, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 26,917,967 | 9999.99% | 0.20% |
| April 3, 2023 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | CFO, Interim CEO & President | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Whitehawk Therapeutics, Inc. | $WHWK | Giacobello Scott M. | Chief Financial Officer | A | Stock option (right to buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |